Learn More
Medchemexpress LLC STAT3-D11-PROTAC-VHL | 96.3% | 1 MG

Supplier: Medchemexpress LLC HY1727671MG
This PROTAC degrader targets Signal Transducer and Activator of Transcription 3 (STAT3). It exhibits anti-tumor activity with IC50 values of 1335 nM and 1973 nM against HeLa and MCF-7 cells, respectively. The compound binds to the DNA-binding domain of STAT3, recruits the E3 ligase VHL to form a ternary complex, leading to ubiquitination and subsequent degradation by the proteasome. It also inhibits tumor cell growth, induces cell cycle arrest and apoptosis, and suppresses tumor immune evasion.
- Degrades STAT3 transcription factor.
- Exhibits anti-tumor activity in HeLa and MCF-7 cells.
- Recruits E3 ligase VHL for STAT3 degradation.
- Inhibits tumor cell growth.
- Induces cell cycle arrest and apoptosis.
- Suppresses tumor immune evasion.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.